| PNEAX | VIVAX | PNEAX / VIVAX | |
| Total Expense Ratio | 1.03 | 0.17 | 606% |
| Annual Report Gross Expense Ratio | 1.03 | 0.17 | 606% |
| Fund Existence | 24 years | 33 years | - |
| Gain YTD | 3.133 | 9.390 | 33% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 476M | 208B | 0% |
| Annual Yield % from dividends | 1.93 | 1.98 | 98% |
| Returns for 1 year | -4.27 | 4.74 | -90% |
| Returns for 3 years | -3.33 | 30.30 | -11% |
| Returns for 5 years | 7.45 | 62.22 | 12% |
| Returns for 10 years | -22.50 | 123.22 | -18% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FNGD | 5.13 | 0.20 | +4.06% |
| MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN | |||
| EPMV | 22.08 | N/A | N/A |
| Harbor Mid Cap Value ETF | |||
| GFEB | 40.50 | -0.13 | -0.32% |
| FT Vest U.S. Eq Mod Buffr ETF - Feb | |||
| QVML | 39.00 | -0.26 | -0.66% |
| Invesco S&P 500 QVM Multi-factor ETF | |||
| BIS | 9.94 | -0.13 | -1.29% |
| ProShares UltraShort Nasdaq Biotech | |||